Press Releases Vicore Pharma Holding AB

Equities

VICO

SE0007577895

Delayed Nasdaq Stockholm Other stock markets 06:31:46 2024-05-23 am EDT			5-day change	1st Jan Change
17.7 ^SEK	-2.21%		-12.38%	+24.82%

May. 07	Vicore Pharma Holding AB Announces Board Appointments	CI
May. 03	Vicore Pharma Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vicore Announces Positive Final Results from the Phase 2a AIR Trial Demonstrating Buloxibutid Improves Lung Function Over 36 Weeks in Patients with Idiopathic Pulmonary Fibrosis	May. 20	AQ
Vicore Expands and Strengthens its Board of Directors	May. 14	AQ
Bulletin from the annual general meeting of Vicore Pharma Holding AB (publ)	May. 07	AQ
Interim report January-March 2024	May. 03	AQ
Vicore to Present at Upcoming April 2024 Investor Conferences	Apr. 15	AQ
Vicore to Present at Upcoming Investor Conferences	Apr. 15	AQ
Vicore to Present at Upcoming Investor Conferences	Apr. 12	AQ
Notice of annual general meeting of Vicore Pharma Holding AB (publ)	Apr. 04	AQ
Vicore Announces Presentations at the 2024 American Thoracic Society International Conference	Mar. 28	AQ
Vicore publishes the Annual Report for 2023	Mar. 27	AQ
Vicore Announces FDA Breakthrough Device Designation for AlmeeTM, a Digital Therapy for Patients with Pulmonary Fibrosis	Mar. 19	AQ
Year-end report 2023	Feb. 28	AQ
Vicore to Present at Upcoming Investor Conferences	Feb. 27	AQ
Vicore and Nippon Shinyaku Enter into an Exclusive License Agreement to Develop and Commercialize C21 in Japan	Feb. 09	AQ
Vicore to Present at Upcoming Investor Conferences	Jan. 31	AQ
Alex Therapeutics Reports Positive Results from the Randomized-Controlled Trial of its Digital Therapy for Anxiety	Jan. 04	AQ
Vicore Reports Positive Results for the Pivotal Study of its Digital Therapy for Patients with Pulmonary Fibrosis	Jan. 04	AQ
Vicore Confirms IPF Development Program on Track and Provides Early-Stage Pipeline Updates	Jan. 02	AQ
Vicore Appoints Leading Respiratory Medicine Developer Dr. Bertil Lindmark MD, PhD, as Chief Medical Officer	Dec. 18	AQ
Vicore to Present at the 2023 DNB Nordic Healthcare Conference	Dec. 11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Vicore Pharma Holding AB

Equities

VICO

SE0007577895

Press Releases

Filters